Sp733
EFFECTIVE ADVOCACY ACROSS PARTY LINES: WHAT TO DO WHEN YOU DON'T LIKE YOUR MEMBER OF CONGRESS
Date
May 8, 2023
Explore related products in the following collection:
Tracks
Related Products
PLACEHOLDER
Perturbations in the gut mucosal immune response contributes to IBD. Non-immune cell popopulations including epithelial and stromal cells also play an important role in intestinal inflammation…
PLACEHOLDER
Switching from originator to biosimilar infliximab (IFX) is effective and safe. However, data on multiple switching are scarce. The Edinburgh IBD unit has undertaken three switch programmes: (1) Remicade to CT-P13 (2016), (2) CT-P13 to SB2 (2020), and (3) SB2 to CT-P13 (2021)…
Q&A
This session is designed to demonstrate successful quality improvement in practices and across institutions with the focus on and meaningful real world implementation across a range of GI conditions…
ADHERENCE TO AGA GUIDELINES FOR GASTROINTESTINAL EVALUATION OF IRON DEFICIENCY ANEMIA
INTRODUCTION: A number of medications have been implicated as primary risk factors for microscopic colitis (MC) and guidelines recommend discontinuation of these medications as part of MC management…